Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 20609987)

1.

Antiretroviral therapy and management of HIV infection.

Volberding PA, Deeks SG.

Lancet. 2010 Jul 3;376(9734):49-62. doi: 10.1016/S0140-6736(10)60676-9. Review.

PMID:
20609987
2.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
3.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.

4.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
5.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
6.

Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.

Buzon MJ, Martin-Gayo E, Pereyra F, Ouyang Z, Sun H, Li JZ, Piovoso M, Shaw A, Dalmau J, Zangger N, Martinez-Picado J, Zurakowski R, Yu XG, Telenti A, Walker BD, Rosenberg ES, Lichterfeld M.

J Virol. 2014 Sep 1;88(17):10056-65. doi: 10.1128/JVI.01046-14. Epub 2014 Jun 25.

7.

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Taiwo B, Murphy RL, Katlama C.

Drugs. 2010 Sep 10;70(13):1629-42. doi: 10.2165/11538020-000000000-00000. Review.

PMID:
20731472
8.

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.

Hosseinipour MC, Gupta RK, Van Zyl G, Eron JJ, Nachega JB.

J Infect Dis. 2013 Jun 15;207 Suppl 2:S49-56. doi: 10.1093/infdis/jit107. Review.

9.

Antiretroviral drugs in HIV-infected children.

Viganò A, Manfredini V, Penagini F, Giacomet V, Zuccotti GV.

Pharmacol Res. 2011 Jul;64(1):1-3. doi: 10.1016/j.phrs.2011.01.007. Epub 2011 Jan 19. Review.

PMID:
21255650
10.

Current status and challenges of antiretroviral research and therapy.

Esté JA, Cihlar T.

Antiviral Res. 2010 Jan;85(1):25-33. doi: 10.1016/j.antiviral.2009.10.007. Epub 2009 Dec 16. Review.

PMID:
20018390
11.

Treatment interruption in HIV therapy: a SMART strategy?

Jülg B, Goebel FD.

Infection. 2006 Jun;34(3):186-8.

PMID:
16804667
12.
13.

[Chronic HIV infection. Current therapeutic aspects].

Vogel M, Rockstroh JK.

Internist (Berl). 2007 May;48(5):519-24; quiz 525. German.

PMID:
17431573
14.
15.

Antiretroviral use during pregnancy for treatment or prophylaxis.

Sturt AS, Read JS.

Expert Opin Pharmacother. 2011 Aug;12(12):1875-85. doi: 10.1517/14656566.2011.584062. Epub 2011 May 3. Review.

PMID:
21534886
16.

Antiretroviral therapy: a primer for dermatologists.

Kim HN, Harrington RD.

Dermatol Clin. 2006 Oct;24(4):537-47, vii. Review.

PMID:
17010782
17.

[Antiviral treatment regimens].

Esser S.

Hautarzt. 2006 Nov;57(11):961-2, 964-8. Review. German.

PMID:
17053925
18.

Effects of antiretroviral therapy on immunity in patients infected with HIV.

Feola DJ, Thornton AC, Garvy BA.

Curr Pharm Des. 2006;12(9):1015-22. Review.

PMID:
16515483
19.

[Antiretroviral therapy of HIV infection].

Imamura A.

Nihon Rinsho. 2012 Apr;70(4):601-6. Review. Japanese.

PMID:
22568140
20.

Adherence to antiretroviral therapy: an update of current concepts.

Lucas GM, Wu AW, Cheever LW.

Curr HIV/AIDS Rep. 2004 Dec;1(4):172-80. Review.

PMID:
16091239
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk